News
An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...
6d
Pharmaceutical Technology on MSNThe GLP-1 drug shortage is over. What’s next for the compounders?Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
12h
The Healthy @Reader's Digest on MSNWhat Is Ozempic Face? 2 Expert Doctors Explain Semaglutide Facial ChangesHighlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
1dOpinion
Montreal Gazette on MSNLabos: Ozempic’s oral counterpart hasn’t caught on yetThe prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
The MOU marks a significant step in strengthening the Kingdom’s healthcare sector and pharmaceutical manufacturing ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results